A prospective, randomized, double-blind, placebo-controlled study to evaluate the safety of a bivalent vaccine of new 6:2 influenza virus reassortants [influenza virus vaccine live] in healthy adults
Phase of Trial: Phase III
Latest Information Update: 17 Dec 2007
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors MedImmune
- 17 Dec 2007 Status changed from in progress to completed.
- 12 Dec 2005 New trial record.